US Patent Issued to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION on June 9 for "Composition for preventing or treating cancer, containing manassantin a and immune checkpoint inhibitor or epithelial growth factor receptor inhibitor" (South Korean Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,925, issued on June 9, was assigned to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Daegu, South Korea).

"Composition for preventing or treating cancer, containing manassantin a and immune checkpoint inhibitor or epithelial growth factor receptor inhibitor" was invented by You-Mie Lee (Gyeongsangbuk-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a method for preventing and/or treating cancer, the method including administering to a subject a composition containing manassantin and an immune checkpoint inhibitor, or manassantin A and an epithelial growth factor receptor inhibitor, as active ingredi...